Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Construction In Progress: ₹21 Mil (As of Mar. 2026)


NSE:MADHAVBAUG Vaidya Sane Ayurved Laboratories Ltd NSE:MADHAVBAUG
84 GF Score
Price ₹182.00
GF Value ₹228.09
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Vaidyane Ayurved Laboratories Construction In Progress?

Vaidyane Ayurved Laboratories NSE:MADHAVBAUG -2.67% 84 Construction In Progress is ₹21 Mil as of Mar. 2026. GuruFocus rates NSE:MADHAVBAUG with a GF Score™ of 84/100 and a GF Value™ of ₹228.09 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Vaidyane Ayurved Laboratories's quarterly construction in progress increased from Mar. 2025 (₹0 Mil) to Sep. 2025 (₹3 Mil) and increased from Sep. 2025 (₹3 Mil) to Mar. 2026 (₹21 Mil).

Vaidyane Ayurved Laboratories's annual construction in progress declined from Mar. 2024 (₹18 Mil) to Mar. 2025 (₹0 Mil) but then increased from Mar. 2025 (₹0 Mil) to Mar. 2026 (₹21 Mil).

Vaidyane Ayurved Laboratories Construction In Progress Historical Data

* Premium members only.

The historical data trend for Vaidyane Ayurved Laboratories's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaidyane Ayurved Laboratories Construction In Progress Chart

Vaidyane Ayurved Laboratories Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial 12.31 16.72 17.60 0.00 21.44

Vaidyane Ayurved Laboratories Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.60 23.92 0.00 3.32 21.44
NSE:MADHAVBAUG
84GF Score
Vaidya Sane Ayurved Laboratories Ltd NSE:MADHAVBAUG
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaidyane Ayurved Laboratories Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹21 Mil mean?
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) has a Construction In Progress of ₹21 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Vaidyane Ayurved Laboratories and its competitors.
Is Vaidyane Ayurved Laboratories' Construction In Progress too high?
Vaidyane Ayurved Laboratories' current Construction In Progress is ₹21 Mil. Overall, Vaidyane Ayurved Laboratories has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaidyane Ayurved Laboratories' Construction In Progress compare to ZTS and UTHR?
Vaidyane Ayurved Laboratories' Construction In Progress of ₹21 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Vaidyane Ayurved Laboratories and its competitors. Vaidyane Ayurved Laboratories's current Construction In Progress is ₹21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaidyane Ayurved Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹228.09, compared to a current price of ₹182.00 — trading 20.2% below its estimated fair value. The current Construction In Progress is ₹21 Mil. Vaidyane Ayurved Laboratories' overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG), the current Construction In Progress is ₹21 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Overvalued in 2026?

Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories stock appears to be undervalued. The current stock price of ₹182.00 is trading 20.2% below its estimated GF Value™ of ₹228.09. GuruFocus considers Vaidyane Ayurved Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:MADHAVBAUG:

  • Construction In Progress: ₹21 Mil
  • GF Value™: ₹228.09 vs. price of ₹182.00 (20.2% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the NSE:MADHAVBAUG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vaidyane Ayurved Laboratories Business Description

Address 201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution. The company engaged in research and development in Ayurvedic Medicines and the sale of Ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurved medical professional services across its various clinics, including panchkarma and other Ayurvedic treatments through the running of an Ayurvedic Hospital. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management, and knee pain relief. The company's business is divided into three segments, i.e., Hospital Activity, Sale of Product, and Common. It derives maximum revenue from the sale of Products.
84GF Score

Get the complete analysis for NSE:MADHAVBAUG

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹182.00
Price
₹228.09
GF Value